They’re all doing it – buying drug research
It is not easy to navigate the complex infrastructure for drug development in Sweden, where various contract players exist alongside the pharmaceutical companies.
According to a report from the Swedish Agency for Growth Policy Analysis, contract research and manufacturing organisations (CRMOs) are among those with the fastest growth in terms of number of They’re all doing it – buying drug research
